Back

Regressive sarcomere shortening response under rate-dependent stress in a murine model of HFpEF and chronic effect of CAMKII inhibition

11 May 2024 (09:00 - 09:45)
Organised by: Logo
Congress Presentation Part of: Chronic heart failure - pathophysiology and mechanisms 1 Heart Failure with Preserved Ejection Fraction (HFpEF) HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Mr Tobias Jeising

Berlin (Germany)

7 More presentations in this session

Presentation thumbnail
Plasma proteomics, myocardial structure, and clinical outcomes in heart failure with preserved ejection fraction: insights from the NETDiamond cohort
Mr A. Razaghizad (Montreal, CA)
Abstract Slides Video
Presentation thumbnail
Diagnostic and therapeutic practices for Heart Failure with preserved ejection fraction around the world: an international survey
Professor C. Saldarriaga (Medellin, CO)
Abstract Slides Video
Presentation thumbnail
Atypical presentation of acute pericarditis revealing pericardial sarcoidosis
Doctor C. Abdelbaki (Montivilliers, FR)
Abstract Slides Video
Presentation thumbnail
Treatment of diastolic dysfunction by targeting beta-adrenergic receptors in vivo in a murine model of cardiometabolic HFpEF
Doctor P. Sander (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Ketones-based signalling in heart failure with preserved ejection fraction (HFpEF)
Mr F. Capone (Padova, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Chronic heart failure - pathophysiology and mechanisms 1

The Event

Event poster

Heart Failure 2024

11 May 2024 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Functional phenotyping combined with single-cell sequencing unmasks potential genes for hypercontractility in murine HFpEF
thumbnail
Congress Presentation
Effects of mavacamten on the cellular response to beta adrenergic and frequency dependent stress in an HFpEF mouse model
thumbnail
Congress Presentation
Effect of the beta-2-selective agonist Salbutamol and the beta-1- selective antagonist Bisoprolol in a murine model of HFpEF

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources